EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Prospective study of 445 lung carcinomas with mediastinal lymph node metastases


Journal of Thoracic and Cardiovascular Surgery 80(3): 390-399
Prospective study of 445 lung carcinomas with mediastinal lymph node metastases
From 1974-1978, 998 patients with carcinoma of the lung were treated. All were staged according to the staging system of The American Joint Committee for Cancer Staging and End Results Reporting. Of these, 445 patients had clinically evident mediastinal lymph node metastases. The condition of 204 was considered inoperable at diagnosis, based on histology of oat cell carcinoma, known distant metastases or malignant effusion. Surgical exploration was undertaken in the remaining 241 patients and they were treated by resection and/or intraoperative implantation of radioactive sources. Of this latter group, 161 (69%) had palliative resection or implantation of radioactive sources. The median survival in this group of patients was 9 mo. There were 80 patients who had complete, potentially curative resection of their primary tumor and all accessible mediastinal lymph nodes. The vast majority of these were also treated by postoperative external radiation therapy to the mediastinum. In this group, there were 25 epidermoid carcinomas, 44 adenocarcinomas, 8 large cell carcinomas and 3 oat cell carcinomas. The survival rate was 73% at 1 yr, 57% at 2 yr and 49% at 3 yr. Survival at 3 yr was slightly better in glandular carcinoma (adenocarcinoma or bronchiolar) than in epidermoid carcinoma (56% vs. 44%). There is a select group of patients with mediastinal lymph node metastases who can be effectively treated by combined resection and radiation therapy, with prolonged survival.

(PDF 0-2 workdays service: $29.90)

Accession: 006206141

PMID: 6251316



Related references

Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases. Annals of Surgery 232(1): 112-118, 2000

Mediastinal ultrasonography for the assessment of mediastinal lymph node metastases in lung cancer patients. Surgery Today (tokyo). 24(2): 106-111, 1994

Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma. Academic Radiology 19(6): 685-692, 2012

Insight into the differences in classification of mediastinal and hilar lymph nodes between Wang's lymph node map and the International Association for the Study of Lung Cancer lymph node map. Journal of Thoracic Disease 7(Suppl 4): S246-S255, 2016

Systemic mediastinal lymph node dissection of right lung cancer: surgical quality control and analysis of mediastinal lymph node metastatic patterns. Interactive Cardiovascular and Thoracic Surgery 7(2): 240-243, 2007

87P: Qualitative and quantitative interpretation of F-18 FDG PET/CT to differentiate metastatic mediastinal lymph node in non-small cell lung carcinoma patients with benign mediastinal lymph node hyperplasia. Journal of Thoracic Oncology 11(4 Suppl): S93-S93, 2016

N 3 lymph node metastases in breast carcinomas important criteria for therapy and prognosis of medial subclavicular lymph node metastases. Langenbecks Archiv fuer Chirurgie 369: 864-865, 1986

Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis. Plos One 9(10): E109979-E109979, 2015

Diagnosis of mediastinal lymph node metastases in lung cancer. Japanese Journal of Clinical Oncology 22(1): 35-40, 1992

Value of FDG PET and TL SPECT in the detection of lung cancer and mediastinal lymph node metastases. Journal of Nuclear Medicine 37(5 SUPPL ): 122P, 1996